Safety and immunogenicity of an mRNA-based RSV vaccine in Japanese older adults aged ≥60 years: A phase 1, randomized, observer-blind, placebo-controlled trial

Autor: Fitz-Patrick, David, Mihara, Hanako, Mills, Anthony, Mithani, Runa, Kapoor, Archana, Dhar, Rakesh, Wilson, Lauren, Guo, Ruiting, Simorellis, Alana K., Panozzo, Catherine A., Reuter, Caroline, Wilson, Eleanor, Chen, Grace L., Stoszek, Sonia K., Shaw, Christine A., Goswami, Jaya
Zdroj: In Respiratory Investigation November 2024 62(6):1037-1043
Databáze: ScienceDirect
Externí odkaz: